Global Bio-pharma Market Insight and Forecast to 2026
The research team projects that the Bio-pharma market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Pfizer
Bayer AG
Sanofi, Amgen
F. Hoffmann-La Roche AG
Biogen Idec
Johnson & Johnson Services
Novartis AG GlaxoSmithKline Plc
Merck & Co., Inc
AbbVie
Eli Lilly and Company
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories
By Type
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
By Application
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Bio-pharma 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Bio-pharma Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Bio-pharma Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Bio-pharma market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Pfizer
Bayer AG
Sanofi, Amgen
F. Hoffmann-La Roche AG
Biogen Idec
Johnson & Johnson Services
Novartis AG GlaxoSmithKline Plc
Merck & Co., Inc
AbbVie
Eli Lilly and Company
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories
By Type
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
By Application
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Bio-pharma 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Bio-pharma Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Bio-pharma Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Bio-pharma market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bio-pharma Revenue
1.4 Market Analysis by Type
1.4.1 Global Bio-pharma Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Recombinant Proteins
1.4.4 Granulocyte-Colony Stimulating Factor (G-CSF)
1.4.5 Interferons
1.4.6 Recombinant Human Insulin
1.4.7 Erythropoietin
1.4.8 Vaccines
1.4.9 Growth Hormones
1.4.10 Purified Proteins
1.5 Market by Application
1.5.1 Global Bio-pharma Market Share by Application: 2021-2026
1.5.2 Metabolic Disorders
1.5.3 Oncology
1.5.4 Neurological Disorders
1.5.5 Cardiovascular Diseases
1.5.6 Inflammatory and Infectious Diseases
1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Bio-pharma Market Perspective (2021-2026)
2.2 Bio-pharma Growth Trends by Regions
2.2.1 Bio-pharma Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Bio-pharma Historic Market Size by Regions (2015-2020)
2.2.3 Bio-pharma Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Bio-pharma Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Bio-pharma Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Bio-pharma Average Price by Manufacturers (2015-2020)
4 BIO-PHARMA PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Bio-pharma Market Size (2015-2026)
4.1.2 Bio-pharma Key Players in North America (2015-2020)
4.1.3 North America Bio-pharma Market Size by Type (2015-2020)
4.1.4 North America Bio-pharma Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Bio-pharma Market Size (2015-2026)
4.2.2 Bio-pharma Key Players in East Asia (2015-2020)
4.2.3 East Asia Bio-pharma Market Size by Type (2015-2020)
4.2.4 East Asia Bio-pharma Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Bio-pharma Market Size (2015-2026)
4.3.2 Bio-pharma Key Players in Europe (2015-2020)
4.3.3 Europe Bio-pharma Market Size by Type (2015-2020)
4.3.4 Europe Bio-pharma Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Bio-pharma Market Size (2015-2026)
4.4.2 Bio-pharma Key Players in South Asia (2015-2020)
4.4.3 South Asia Bio-pharma Market Size by Type (2015-2020)
4.4.4 South Asia Bio-pharma Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Bio-pharma Market Size (2015-2026)
4.5.2 Bio-pharma Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Bio-pharma Market Size by Type (2015-2020)
4.5.4 Southeast Asia Bio-pharma Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Bio-pharma Market Size (2015-2026)
4.6.2 Bio-pharma Key Players in Middle East (2015-2020)
4.6.3 Middle East Bio-pharma Market Size by Type (2015-2020)
4.6.4 Middle East Bio-pharma Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Bio-pharma Market Size (2015-2026)
4.7.2 Bio-pharma Key Players in Africa (2015-2020)
4.7.3 Africa Bio-pharma Market Size by Type (2015-2020)
4.7.4 Africa Bio-pharma Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Bio-pharma Market Size (2015-2026)
4.8.2 Bio-pharma Key Players in Oceania (2015-2020)
4.8.3 Oceania Bio-pharma Market Size by Type (2015-2020)
4.8.4 Oceania Bio-pharma Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Bio-pharma Market Size (2015-2026)
4.9.2 Bio-pharma Key Players in South America (2015-2020)
4.9.3 South America Bio-pharma Market Size by Type (2015-2020)
4.9.4 South America Bio-pharma Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Bio-pharma Market Size (2015-2026)
4.10.2 Bio-pharma Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Bio-pharma Market Size by Type (2015-2020)
4.10.4 Rest of the World Bio-pharma Market Size by Application (2015-2020)
5 BIO-PHARMA CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Bio-pharma Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Bio-pharma Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Bio-pharma Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Bio-pharma Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Bio-pharma Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Bio-pharma Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Bio-pharma Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Bio-pharma Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Bio-pharma Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Bio-pharma Consumption by Countries
5.10.2 Kazakhstan
6 BIO-PHARMA SALES MARKET BY TYPE (2015-2026)
6.1 Global Bio-pharma Historic Market Size by Type (2015-2020)
6.2 Global Bio-pharma Forecasted Market Size by Type (2021-2026)
7 BIO-PHARMA CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Bio-pharma Historic Market Size by Application (2015-2020)
7.2 Global Bio-pharma Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN BIO-PHARMA BUSINESS
8.1 Pfizer
8.1.1 Pfizer Company Profile
8.1.2 Pfizer Bio-pharma Product Specification
8.1.3 Pfizer Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Bayer AG
8.2.1 Bayer AG Company Profile
8.2.2 Bayer AG Bio-pharma Product Specification
8.2.3 Bayer AG Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Sanofi, Amgen
8.3.1 Sanofi, Amgen Company Profile
8.3.2 Sanofi, Amgen Bio-pharma Product Specification
8.3.3 Sanofi, Amgen Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 F. Hoffmann-La Roche AG
8.4.1 F. Hoffmann-La Roche AG Company Profile
8.4.2 F. Hoffmann-La Roche AG Bio-pharma Product Specification
8.4.3 F. Hoffmann-La Roche AG Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Biogen Idec
8.5.1 Biogen Idec Company Profile
8.5.2 Biogen Idec Bio-pharma Product Specification
8.5.3 Biogen Idec Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Johnson & Johnson Services
8.6.1 Johnson & Johnson Services Company Profile
8.6.2 Johnson & Johnson Services Bio-pharma Product Specification
8.6.3 Johnson & Johnson Services Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Novartis AG GlaxoSmithKline Plc
8.7.1 Novartis AG GlaxoSmithKline Plc Company Profile
8.7.2 Novartis AG GlaxoSmithKline Plc Bio-pharma Product Specification
8.7.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Merck & Co., Inc
8.8.1 Merck & Co., Inc Company Profile
8.8.2 Merck & Co., Inc Bio-pharma Product Specification
8.8.3 Merck & Co., Inc Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 AbbVie
8.9.1 AbbVie Company Profile
8.9.2 AbbVie Bio-pharma Product Specification
8.9.3 AbbVie Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Eli Lilly and Company
8.10.1 Eli Lilly and Company Company Profile
8.10.2 Eli Lilly and Company Bio-pharma Product Specification
8.10.3 Eli Lilly and Company Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Bristol-Myers Squibb Company
8.11.1 Bristol-Myers Squibb Company Company Profile
8.11.2 Bristol-Myers Squibb Company Bio-pharma Product Specification
8.11.3 Bristol-Myers Squibb Company Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 AstraZeneca PLC
8.12.1 AstraZeneca PLC Company Profile
8.12.2 AstraZeneca PLC Bio-pharma Product Specification
8.12.3 AstraZeneca PLC Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Abbott Laboratories
8.13.1 Abbott Laboratories Company Profile
8.13.2 Abbott Laboratories Bio-pharma Product Specification
8.13.3 Abbott Laboratories Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Bio-pharma (2021-2026)
9.2 Global Forecasted Revenue of Bio-pharma (2021-2026)
9.3 Global Forecasted Price of Bio-pharma (2015-2026)
9.4 Global Forecasted Production of Bio-pharma by Region (2021-2026)
9.4.1 North America Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.3 Europe Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.7 Africa Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.9 South America Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Bio-pharma Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Bio-pharma by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Bio-pharma by Country
10.2 East Asia Market Forecasted Consumption of Bio-pharma by Country
10.3 Europe Market Forecasted Consumption of Bio-pharma by Countriy
10.4 South Asia Forecasted Consumption of Bio-pharma by Country
10.5 Southeast Asia Forecasted Consumption of Bio-pharma by Country
10.6 Middle East Forecasted Consumption of Bio-pharma by Country
10.7 Africa Forecasted Consumption of Bio-pharma by Country
10.8 Oceania Forecasted Consumption of Bio-pharma by Country
10.9 South America Forecasted Consumption of Bio-pharma by Country
10.10 Rest of the world Forecasted Consumption of Bio-pharma by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Bio-pharma Distributors List
11.3 Bio-pharma Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Bio-pharma Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bio-pharma Revenue
1.4 Market Analysis by Type
1.4.1 Global Bio-pharma Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Recombinant Proteins
1.4.4 Granulocyte-Colony Stimulating Factor (G-CSF)
1.4.5 Interferons
1.4.6 Recombinant Human Insulin
1.4.7 Erythropoietin
1.4.8 Vaccines
1.4.9 Growth Hormones
1.4.10 Purified Proteins
1.5 Market by Application
1.5.1 Global Bio-pharma Market Share by Application: 2021-2026
1.5.2 Metabolic Disorders
1.5.3 Oncology
1.5.4 Neurological Disorders
1.5.5 Cardiovascular Diseases
1.5.6 Inflammatory and Infectious Diseases
1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Bio-pharma Market Perspective (2021-2026)
2.2 Bio-pharma Growth Trends by Regions
2.2.1 Bio-pharma Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Bio-pharma Historic Market Size by Regions (2015-2020)
2.2.3 Bio-pharma Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Bio-pharma Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Bio-pharma Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Bio-pharma Average Price by Manufacturers (2015-2020)
4 BIO-PHARMA PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Bio-pharma Market Size (2015-2026)
4.1.2 Bio-pharma Key Players in North America (2015-2020)
4.1.3 North America Bio-pharma Market Size by Type (2015-2020)
4.1.4 North America Bio-pharma Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Bio-pharma Market Size (2015-2026)
4.2.2 Bio-pharma Key Players in East Asia (2015-2020)
4.2.3 East Asia Bio-pharma Market Size by Type (2015-2020)
4.2.4 East Asia Bio-pharma Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Bio-pharma Market Size (2015-2026)
4.3.2 Bio-pharma Key Players in Europe (2015-2020)
4.3.3 Europe Bio-pharma Market Size by Type (2015-2020)
4.3.4 Europe Bio-pharma Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Bio-pharma Market Size (2015-2026)
4.4.2 Bio-pharma Key Players in South Asia (2015-2020)
4.4.3 South Asia Bio-pharma Market Size by Type (2015-2020)
4.4.4 South Asia Bio-pharma Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Bio-pharma Market Size (2015-2026)
4.5.2 Bio-pharma Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Bio-pharma Market Size by Type (2015-2020)
4.5.4 Southeast Asia Bio-pharma Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Bio-pharma Market Size (2015-2026)
4.6.2 Bio-pharma Key Players in Middle East (2015-2020)
4.6.3 Middle East Bio-pharma Market Size by Type (2015-2020)
4.6.4 Middle East Bio-pharma Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Bio-pharma Market Size (2015-2026)
4.7.2 Bio-pharma Key Players in Africa (2015-2020)
4.7.3 Africa Bio-pharma Market Size by Type (2015-2020)
4.7.4 Africa Bio-pharma Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Bio-pharma Market Size (2015-2026)
4.8.2 Bio-pharma Key Players in Oceania (2015-2020)
4.8.3 Oceania Bio-pharma Market Size by Type (2015-2020)
4.8.4 Oceania Bio-pharma Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Bio-pharma Market Size (2015-2026)
4.9.2 Bio-pharma Key Players in South America (2015-2020)
4.9.3 South America Bio-pharma Market Size by Type (2015-2020)
4.9.4 South America Bio-pharma Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Bio-pharma Market Size (2015-2026)
4.10.2 Bio-pharma Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Bio-pharma Market Size by Type (2015-2020)
4.10.4 Rest of the World Bio-pharma Market Size by Application (2015-2020)
5 BIO-PHARMA CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Bio-pharma Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Bio-pharma Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Bio-pharma Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Bio-pharma Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Bio-pharma Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Bio-pharma Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Bio-pharma Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Bio-pharma Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Bio-pharma Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Bio-pharma Consumption by Countries
5.10.2 Kazakhstan
6 BIO-PHARMA SALES MARKET BY TYPE (2015-2026)
6.1 Global Bio-pharma Historic Market Size by Type (2015-2020)
6.2 Global Bio-pharma Forecasted Market Size by Type (2021-2026)
7 BIO-PHARMA CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Bio-pharma Historic Market Size by Application (2015-2020)
7.2 Global Bio-pharma Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN BIO-PHARMA BUSINESS
8.1 Pfizer
8.1.1 Pfizer Company Profile
8.1.2 Pfizer Bio-pharma Product Specification
8.1.3 Pfizer Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Bayer AG
8.2.1 Bayer AG Company Profile
8.2.2 Bayer AG Bio-pharma Product Specification
8.2.3 Bayer AG Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Sanofi, Amgen
8.3.1 Sanofi, Amgen Company Profile
8.3.2 Sanofi, Amgen Bio-pharma Product Specification
8.3.3 Sanofi, Amgen Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 F. Hoffmann-La Roche AG
8.4.1 F. Hoffmann-La Roche AG Company Profile
8.4.2 F. Hoffmann-La Roche AG Bio-pharma Product Specification
8.4.3 F. Hoffmann-La Roche AG Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Biogen Idec
8.5.1 Biogen Idec Company Profile
8.5.2 Biogen Idec Bio-pharma Product Specification
8.5.3 Biogen Idec Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Johnson & Johnson Services
8.6.1 Johnson & Johnson Services Company Profile
8.6.2 Johnson & Johnson Services Bio-pharma Product Specification
8.6.3 Johnson & Johnson Services Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Novartis AG GlaxoSmithKline Plc
8.7.1 Novartis AG GlaxoSmithKline Plc Company Profile
8.7.2 Novartis AG GlaxoSmithKline Plc Bio-pharma Product Specification
8.7.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Merck & Co., Inc
8.8.1 Merck & Co., Inc Company Profile
8.8.2 Merck & Co., Inc Bio-pharma Product Specification
8.8.3 Merck & Co., Inc Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 AbbVie
8.9.1 AbbVie Company Profile
8.9.2 AbbVie Bio-pharma Product Specification
8.9.3 AbbVie Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Eli Lilly and Company
8.10.1 Eli Lilly and Company Company Profile
8.10.2 Eli Lilly and Company Bio-pharma Product Specification
8.10.3 Eli Lilly and Company Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Bristol-Myers Squibb Company
8.11.1 Bristol-Myers Squibb Company Company Profile
8.11.2 Bristol-Myers Squibb Company Bio-pharma Product Specification
8.11.3 Bristol-Myers Squibb Company Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 AstraZeneca PLC
8.12.1 AstraZeneca PLC Company Profile
8.12.2 AstraZeneca PLC Bio-pharma Product Specification
8.12.3 AstraZeneca PLC Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Abbott Laboratories
8.13.1 Abbott Laboratories Company Profile
8.13.2 Abbott Laboratories Bio-pharma Product Specification
8.13.3 Abbott Laboratories Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Bio-pharma (2021-2026)
9.2 Global Forecasted Revenue of Bio-pharma (2021-2026)
9.3 Global Forecasted Price of Bio-pharma (2015-2026)
9.4 Global Forecasted Production of Bio-pharma by Region (2021-2026)
9.4.1 North America Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.3 Europe Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.7 Africa Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.9 South America Bio-pharma Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Bio-pharma Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Bio-pharma by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Bio-pharma by Country
10.2 East Asia Market Forecasted Consumption of Bio-pharma by Country
10.3 Europe Market Forecasted Consumption of Bio-pharma by Countriy
10.4 South Asia Forecasted Consumption of Bio-pharma by Country
10.5 Southeast Asia Forecasted Consumption of Bio-pharma by Country
10.6 Middle East Forecasted Consumption of Bio-pharma by Country
10.7 Africa Forecasted Consumption of Bio-pharma by Country
10.8 Oceania Forecasted Consumption of Bio-pharma by Country
10.9 South America Forecasted Consumption of Bio-pharma by Country
10.10 Rest of the world Forecasted Consumption of Bio-pharma by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Bio-pharma Distributors List
11.3 Bio-pharma Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Bio-pharma Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global Bio-pharma Market Share by Type: 2020 VS 2026
Table 2. Monoclonal Antibodies Features
Table 3. Recombinant Proteins Features
Table 4. Granulocyte-Colony Stimulating Factor (G-CSF) Features
Table 5. Interferons Features
Table 6. Recombinant Human Insulin Features
Table 7. Erythropoietin Features
Table 8. Vaccines Features
Table 9. Growth Hormones Features
Table 10. Purified Proteins Features
Table 11. Global Bio-pharma Market Share by Application: 2020 VS 2026
Table 12. Metabolic Disorders Case Studies
Table 13. Oncology Case Studies
Table 14. Neurological Disorders Case Studies
Table 15. Cardiovascular Diseases Case Studies
Table 16. Inflammatory and Infectious Diseases Case Studies
Table 17. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Bio-pharma Report Years Considered
Table 29. Global Bio-pharma Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Bio-pharma Market Share by Regions: 2021 VS 2026
Table 31. North America Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Bio-pharma Consumption by Countries (2015-2020)
Table 42. East Asia Bio-pharma Consumption by Countries (2015-2020)
Table 43. Europe Bio-pharma Consumption by Region (2015-2020)
Table 44. South Asia Bio-pharma Consumption by Countries (2015-2020)
Table 45. Southeast Asia Bio-pharma Consumption by Countries (2015-2020)
Table 46. Middle East Bio-pharma Consumption by Countries (2015-2020)
Table 47. Africa Bio-pharma Consumption by Countries (2015-2020)
Table 48. Oceania Bio-pharma Consumption by Countries (2015-2020)
Table 49. South America Bio-pharma Consumption by Countries (2015-2020)
Table 50. Rest of the World Bio-pharma Consumption by Countries (2015-2020)
Table 51. Pfizer Bio-pharma Product Specification
Table 52. Bayer AG Bio-pharma Product Specification
Table 53. Sanofi, Amgen Bio-pharma Product Specification
Table 54. F. Hoffmann-La Roche AG Bio-pharma Product Specification
Table 55. Biogen Idec Bio-pharma Product Specification
Table 56. Johnson & Johnson Services Bio-pharma Product Specification
Table 57. Novartis AG GlaxoSmithKline Plc Bio-pharma Product Specification
Table 58. Merck & Co., Inc Bio-pharma Product Specification
Table 59. AbbVie Bio-pharma Product Specification
Table 60. Eli Lilly and Company Bio-pharma Product Specification
Table 61. Bristol-Myers Squibb Company Bio-pharma Product Specification
Table 62. AstraZeneca PLC Bio-pharma Product Specification
Table 63. Abbott Laboratories Bio-pharma Product Specification
Table 101. Global Bio-pharma Production Forecast by Region (2021-2026)
Table 102. Global Bio-pharma Sales Volume Forecast by Type (2021-2026)
Table 103. Global Bio-pharma Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Bio-pharma Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Bio-pharma Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Bio-pharma Sales Price Forecast by Type (2021-2026)
Table 107. Global Bio-pharma Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Bio-pharma Consumption Value Forecast by Application (2021-2026)
Table 109. North America Bio-pharma Consumption Forecast 2021-2026 by Country
Table 110. East Asia Bio-pharma Consumption Forecast 2021-2026 by Country
Table 111. Europe Bio-pharma Consumption Forecast 2021-2026 by Country
Table 112. South Asia Bio-pharma Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Bio-pharma Consumption Forecast 2021-2026 by Country
Table 114. Middle East Bio-pharma Consumption Forecast 2021-2026 by Country
Table 115. Africa Bio-pharma Consumption Forecast 2021-2026 by Country
Table 116. Oceania Bio-pharma Consumption Forecast 2021-2026 by Country
Table 117. South America Bio-pharma Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Bio-pharma Consumption Forecast 2021-2026 by Country
Table 119. Bio-pharma Distributors List
Table 120. Bio-pharma Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 2. North America Bio-pharma Consumption Market Share by Countries in 2020
Figure 3. United States Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 4. Canada Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Bio-pharma Consumption Market Share by Countries in 2020
Figure 8. China Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 9. Japan Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 11. Europe Bio-pharma Consumption and Growth Rate
Figure 12. Europe Bio-pharma Consumption Market Share by Region in 2020
Figure 13. Germany Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 15. France Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 16. Italy Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 17. Russia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 18. Spain Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 21. Poland Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Bio-pharma Consumption and Growth Rate
Figure 23. South Asia Bio-pharma Consumption Market Share by Countries in 2020
Figure 24. India Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Bio-pharma Consumption and Growth Rate
Figure 28. Southeast Asia Bio-pharma Consumption Market Share by Countries in 2020
Figure 29. Indonesia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Bio-pharma Consumption and Growth Rate
Figure 37. Middle East Bio-pharma Consumption Market Share by Countries in 2020
Figure 38. Turkey Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 40. Iran Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 42. Israel Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 46. Oman Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 47. Africa Bio-pharma Consumption and Growth Rate
Figure 48. Africa Bio-pharma Consumption Market Share by Countries in 2020
Figure 49. Nigeria Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Bio-pharma Consumption and Growth Rate
Figure 55. Oceania Bio-pharma Consumption Market Share by Countries in 2020
Figure 56. Australia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 58. South America Bio-pharma Consumption and Growth Rate
Figure 59. South America Bio-pharma Consumption Market Share by Countries in 2020
Figure 60. Brazil Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 63. Chile Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 65. Peru Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Bio-pharma Consumption and Growth Rate
Figure 69. Rest of the World Bio-pharma Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 71. Global Bio-pharma Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Bio-pharma Price and Trend Forecast (2015-2026)
Figure 74. North America Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 75. North America Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 91. South America Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Bio-pharma Consumption Forecast 2021-2026
Figure 95. East Asia Bio-pharma Consumption Forecast 2021-2026
Figure 96. Europe Bio-pharma Consumption Forecast 2021-2026
Figure 97. South Asia Bio-pharma Consumption Forecast 2021-2026
Figure 98. Southeast Asia Bio-pharma Consumption Forecast 2021-2026
Figure 99. Middle East Bio-pharma Consumption Forecast 2021-2026
Figure 100. Africa Bio-pharma Consumption Forecast 2021-2026
Figure 101. Oceania Bio-pharma Consumption Forecast 2021-2026
Figure 102. South America Bio-pharma Consumption Forecast 2021-2026
Figure 103. Rest of the world Bio-pharma Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global Bio-pharma Market Share by Type: 2020 VS 2026
Table 2. Monoclonal Antibodies Features
Table 3. Recombinant Proteins Features
Table 4. Granulocyte-Colony Stimulating Factor (G-CSF) Features
Table 5. Interferons Features
Table 6. Recombinant Human Insulin Features
Table 7. Erythropoietin Features
Table 8. Vaccines Features
Table 9. Growth Hormones Features
Table 10. Purified Proteins Features
Table 11. Global Bio-pharma Market Share by Application: 2020 VS 2026
Table 12. Metabolic Disorders Case Studies
Table 13. Oncology Case Studies
Table 14. Neurological Disorders Case Studies
Table 15. Cardiovascular Diseases Case Studies
Table 16. Inflammatory and Infectious Diseases Case Studies
Table 17. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Bio-pharma Report Years Considered
Table 29. Global Bio-pharma Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Bio-pharma Market Share by Regions: 2021 VS 2026
Table 31. North America Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Bio-pharma Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Bio-pharma Consumption by Countries (2015-2020)
Table 42. East Asia Bio-pharma Consumption by Countries (2015-2020)
Table 43. Europe Bio-pharma Consumption by Region (2015-2020)
Table 44. South Asia Bio-pharma Consumption by Countries (2015-2020)
Table 45. Southeast Asia Bio-pharma Consumption by Countries (2015-2020)
Table 46. Middle East Bio-pharma Consumption by Countries (2015-2020)
Table 47. Africa Bio-pharma Consumption by Countries (2015-2020)
Table 48. Oceania Bio-pharma Consumption by Countries (2015-2020)
Table 49. South America Bio-pharma Consumption by Countries (2015-2020)
Table 50. Rest of the World Bio-pharma Consumption by Countries (2015-2020)
Table 51. Pfizer Bio-pharma Product Specification
Table 52. Bayer AG Bio-pharma Product Specification
Table 53. Sanofi, Amgen Bio-pharma Product Specification
Table 54. F. Hoffmann-La Roche AG Bio-pharma Product Specification
Table 55. Biogen Idec Bio-pharma Product Specification
Table 56. Johnson & Johnson Services Bio-pharma Product Specification
Table 57. Novartis AG GlaxoSmithKline Plc Bio-pharma Product Specification
Table 58. Merck & Co., Inc Bio-pharma Product Specification
Table 59. AbbVie Bio-pharma Product Specification
Table 60. Eli Lilly and Company Bio-pharma Product Specification
Table 61. Bristol-Myers Squibb Company Bio-pharma Product Specification
Table 62. AstraZeneca PLC Bio-pharma Product Specification
Table 63. Abbott Laboratories Bio-pharma Product Specification
Table 101. Global Bio-pharma Production Forecast by Region (2021-2026)
Table 102. Global Bio-pharma Sales Volume Forecast by Type (2021-2026)
Table 103. Global Bio-pharma Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Bio-pharma Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Bio-pharma Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Bio-pharma Sales Price Forecast by Type (2021-2026)
Table 107. Global Bio-pharma Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Bio-pharma Consumption Value Forecast by Application (2021-2026)
Table 109. North America Bio-pharma Consumption Forecast 2021-2026 by Country
Table 110. East Asia Bio-pharma Consumption Forecast 2021-2026 by Country
Table 111. Europe Bio-pharma Consumption Forecast 2021-2026 by Country
Table 112. South Asia Bio-pharma Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Bio-pharma Consumption Forecast 2021-2026 by Country
Table 114. Middle East Bio-pharma Consumption Forecast 2021-2026 by Country
Table 115. Africa Bio-pharma Consumption Forecast 2021-2026 by Country
Table 116. Oceania Bio-pharma Consumption Forecast 2021-2026 by Country
Table 117. South America Bio-pharma Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Bio-pharma Consumption Forecast 2021-2026 by Country
Table 119. Bio-pharma Distributors List
Table 120. Bio-pharma Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 2. North America Bio-pharma Consumption Market Share by Countries in 2020
Figure 3. United States Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 4. Canada Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Bio-pharma Consumption Market Share by Countries in 2020
Figure 8. China Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 9. Japan Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 11. Europe Bio-pharma Consumption and Growth Rate
Figure 12. Europe Bio-pharma Consumption Market Share by Region in 2020
Figure 13. Germany Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 15. France Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 16. Italy Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 17. Russia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 18. Spain Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 21. Poland Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Bio-pharma Consumption and Growth Rate
Figure 23. South Asia Bio-pharma Consumption Market Share by Countries in 2020
Figure 24. India Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Bio-pharma Consumption and Growth Rate
Figure 28. Southeast Asia Bio-pharma Consumption Market Share by Countries in 2020
Figure 29. Indonesia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Bio-pharma Consumption and Growth Rate
Figure 37. Middle East Bio-pharma Consumption Market Share by Countries in 2020
Figure 38. Turkey Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 40. Iran Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 42. Israel Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 46. Oman Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 47. Africa Bio-pharma Consumption and Growth Rate
Figure 48. Africa Bio-pharma Consumption Market Share by Countries in 2020
Figure 49. Nigeria Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Bio-pharma Consumption and Growth Rate
Figure 55. Oceania Bio-pharma Consumption Market Share by Countries in 2020
Figure 56. Australia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 58. South America Bio-pharma Consumption and Growth Rate
Figure 59. South America Bio-pharma Consumption Market Share by Countries in 2020
Figure 60. Brazil Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 63. Chile Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 65. Peru Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Bio-pharma Consumption and Growth Rate
Figure 69. Rest of the World Bio-pharma Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Bio-pharma Consumption and Growth Rate (2015-2020)
Figure 71. Global Bio-pharma Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Bio-pharma Price and Trend Forecast (2015-2026)
Figure 74. North America Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 75. North America Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 91. South America Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Bio-pharma Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Bio-pharma Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Bio-pharma Consumption Forecast 2021-2026
Figure 95. East Asia Bio-pharma Consumption Forecast 2021-2026
Figure 96. Europe Bio-pharma Consumption Forecast 2021-2026
Figure 97. South Asia Bio-pharma Consumption Forecast 2021-2026
Figure 98. Southeast Asia Bio-pharma Consumption Forecast 2021-2026
Figure 99. Middle East Bio-pharma Consumption Forecast 2021-2026
Figure 100. Africa Bio-pharma Consumption Forecast 2021-2026
Figure 101. Oceania Bio-pharma Consumption Forecast 2021-2026
Figure 102. South America Bio-pharma Consumption Forecast 2021-2026
Figure 103. Rest of the world Bio-pharma Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
